Education
About Us
Working with TipRanks
Follow Us
Inovio Pharmaceuticals (INO)
:INO
Ino-9112, Cellectra® 2000, Ino-4800
Coronavirus Infection
Phase I
Withdrawn
Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers
Jun 21, 2022
―
Cellectra® 2000, Ino-4800
Coronavirus Infection, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Covid-19 Disease
Phase II/III
Terminated
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
Nov 23, 2020
―
Cellectra™ 2000, Ino-4700
Middle East Respiratory Syndrome Coronavirus (Mers-Cov)
Phase II
Completed
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
Oct 06, 2020
―
Cellectra™ 2000, Ino-3107
Respiratory Papillomatosis
Phase I/II
Completed
INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)
May 14, 2020
―
Cellectra® 2000, Ino-4800
Coronavirus Infection
Phase I
Completed
Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers
Apr 03, 2020
―
Ino-4500, Cellectra™ 2000
Lassa Fever
Phase I
Completed
Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana
Sep 16, 2019
―
Ino-4500, Cellectra® 2000
Lassa Fever
Phase I
Completed
Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers
Jan 14, 2019
―
Vgx-3100, Cellectra™-5Psp
Cervical Dysplasia, Cervical High Grade Squamous Intraepithelial Lesion, Hsil
Phase III
Completed
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Oct 25, 2018
―
Gls-6150
Hcv Infection
Phase I
Completed
Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection
Sep 14, 2018
―
Gls-5300, Cellectra 2000 Electroporation
Healthy
Phase I/II
Completed
Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers
Sep 11, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Inovio Pharmaceuticals (INO) have in its pipeline
INO is currently developing the following drugs: Ino-9112, Cellectra® 2000, Ino-4800, Cellectra® 2000, Ino-4800, Cellectra™ 2000, Ino-4700. These drug candidates are in various stages of clinical development as the company works toward FDA approval.